RE:7 Cannabis Stocks That Cantor Fitzgerald RecommendsFundamentally I agree. But then we have days like today where Canopy Growth is named in a significant lawsuit and yet their share price rises more than APHA's. I fully realize the short term day to day price swings are not to be take too much to heart (like weather verses climate change) but sheesh. Now Tilray is on a tear and we bumble along. At some point, some day, some time, who knows, Aphria has to come into its own. So many years...so many missteps.
Daredevil1964 wrote: https://finance.yahoo.com/news/7-cannabis-stocks-cantor-fitzgerald-193159230.html https://finance.yahoo.com/news/7-cannabis-stocks-cantor-fitzgerald-193159230.html
Aphria (APHA)
Canadian cannabis producer Aphria disappointed investors with its fourth-quarter earnings report. Revenue was up 18% from a year ago but just 5% from the third quarter. Like many other cannabis stocks, Aphria also recorded a nearly $50 million impairment charge during the quarter. Zuanic says the headline numbers may not have been particularly impressive, but Aphria's 27% sequential recreational cannabis sales growth tripled the average growth rate of its Canadian peers. Earnings before interest, taxes, depreciation and amortization, or EBITDA, margins also surpassed competitors, Zuanic says. Cantor Fitzgerald has an "overweight" rating and $9.48 price target for APHA stock.